Unlock stock picks and a broker-level newsfeed that powers Wall Street.
LSE - Delayed Quote GBp

Reckitt Benckiser Group plc (RKT.L)

Compare
5,230.00
-2.00
(-0.04%)
At close: March 31 at 4:47:23 PM GMT+1
Loading Chart for RKT.L
  • Previous Close 5,232.00
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 5,418.00
  • Volume 712
  • Avg. Volume 1,423,422
  • Market Cap (intraday) 35.716B
  • Beta (5Y Monthly) 0.07
  • PE Ratio (TTM) 25.64
  • EPS (TTM) 2.04
  • Earnings Date Mar 6, 2025
  • Forward Dividend & Yield 2.02 (3.86%)
  • Ex-Dividend Date Apr 10, 2025
  • 1y Target Est 5,854.12

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under Airborne, Movefree, and neuriva names; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.

www.reckitt.com

37,900

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RKT.L

View More

Performance Overview: RKT.L

Trailing total returns as of 3/31/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

RKT.L
8.21%
FTSE 100 (^FTSE)
5.01%

1-Year Return

RKT.L
15.97%
FTSE 100 (^FTSE)
7.92%

3-Year Return

RKT.L
10.23%
FTSE 100 (^FTSE)
14.20%

5-Year Return

RKT.L
14.82%
FTSE 100 (^FTSE)
51.32%

Compare To: RKT.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RKT.L

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    35.73B

  • Enterprise Value

    43.63B

  • Trailing P/E

    25.67

  • Forward P/E

    16.05

  • PEG Ratio (5yr expected)

    1.37

  • Price/Sales (ttm)

    2.59

  • Price/Book (mrq)

    5.33

  • Enterprise Value/Revenue

    3.08

  • Enterprise Value/EBITDA

    14.75

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.06%

  • Return on Assets (ttm)

    8.22%

  • Return on Equity (ttm)

    18.86%

  • Revenue (ttm)

    14.17B

  • Net Income Avi to Common (ttm)

    1.43B

  • Diluted EPS (ttm)

    2.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    880M

  • Total Debt/Equity (mrq)

    131.41%

  • Levered Free Cash Flow (ttm)

    2.11B

Research Analysis: RKT.L

View More

Company Insights: RKT.L

Research Reports: RKT.L

View More

People Also Watch